Immunogenetics of HIV and HIV associated tuberculosis

Tuberculosis

Volumn 92, Issue 1, 2012, Pages 18-30

  Raghavan, S ^a   Alagarasu, K ^a   Selvaraj, P ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Chemokine; Gene polymorphisms; HIV; HIV TB; HLA

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CALCITRIOL; CD209 ANTIGEN; CD4 ANTIGEN; CYCLOPHILIN A; HLA A29 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA B22 ANTIGEN; HLA B35 ANTIGEN; HLA B57 ANTIGEN; HLA C14 ANTIGEN; HLA C8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MANNOSE BINDING LECTIN 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PURINERGIC P2X7 RECEPTOR; RANTES; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ALLELE; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENETICS; MIXED INFECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TH1 CELL; TH2 CELL; TUBERCULOSIS;

AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BRAZIL; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIV-1; HUMANS; INDIA; MALE; POLYMORPHISM, GENETIC; TUBERCULOSIS;

EID: 84856422475     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.08.004     Document Type: Review

References (174)

1. S.K. Sharma, A. Mohan, and T. Kadhiravan HIV-TB co-infection: epidemiology, diagnosis & management Indian J Med Res 121 2005 550 567 (Pubitemid 40691382)
2. S. Swaminathan, R. Ramachandran, G. Baskaran, C.N. Paramasivan, U. Ramanathan, and P. Venkatesan Risk of development of tuberculosis in HIV-infected patients Int J Tuberc Lung Dis 4 2000 839 844
3. A. Singh, I. Bairy, and P.G. Shivananda Spectrum of opportunistic infections in AIDS cases Indian J Med Sci 57 2003 16 21 (Pubitemid 39663088)
4. D. Podlekareva, A. Mocroft, U.B. Dragsted, B. Ledergerber, M. Beniowski, and A. Lazzarin Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study J Infect Dis 194 2006 633 641 (Pubitemid 44297849)
5. S.J. O'Brien, and G.W. Nelson Human genes that limit AIDS Nat Genet 36 2004 565 574 (Pubitemid 38715980)
6. L.G. Louie, W.E. Hartogensis, R.P. Jackman, K.A. Schultz, L.S. Zijenah, and C.H. Yiu Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variation J Infect Dis 189 2004 1084 1090 (Pubitemid 38373101)
7. J.F. Figueiredo, L. Rodrigues Mde, N.H. Deghaide, and E.A. Donadi HLA profile in patients with AIDS and tuberculosis Braz J Infect Dis 12 2008 278 280
8. P. Selvaraj, S. Swaminathan, K. Alagarasu, S. Raghavan, G. Narendran, and P. Narayanan Association of human leukocyte antigen-A11 with resistance and B40 and DR2 with susceptibility to HIV-1 infection in south India J Acquir Immune Defic Syndr 43 2006 497 499 (Pubitemid 44737110)
9. S. Raghavan, P. Selvaraj, S. Swaminathan, and G. Narendran Short communication: association of HLA-A (*)1101 with resistance and B (*)4006 with susceptibility to HIV and HIV-TB: an in silico analysis of promiscuous T cell epitopes AIDS Res Hum Retroviruses 25 2009 1023 1028
10. S. Raghavan, P. Selvaraj, S. Swaminathan, K. Alagarasu, G. Narendran, and P.R. Narayanan Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosis Int J Immunogenet 36 2009 129 133
11. P. Selvaraj, S. Raghavan, S. Swaminathan, K. Alagarasu, G. Narendran, and P.R. Narayanan HLA-DQB1 and -DPB1 allele profile in HIV infected patients with and without pulmonary tuberculosis of south India Infect Genet Evol 8 2008 664 671
12. P. Singh, G. Kaur, G. Sharma, and N.K. Mehra Immunogenetic basis of HIV-1 infection, transmission and disease progression Vaccine 26 2008 2966 2980
13. U. Shankarkumar, A. Pawar, G. Prabu, and K. Ghosh Role of HLA class I (HLA-A, B) and HLA class II (HLA-DRB, DQB) in HIV-1 patients with and without pulmonary tuberculosis J Acquir Immune Defic Syndr 51 2009 640 641
14. M.I. Garcia-Laorden, M.J. Pena, J.A. Caminero, A. Garcia-Saavedra, M.I. Campos-Herrero, and A. Caballero Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population Mol Immunol 43 2006 2143 2150 (Pubitemid 43831201)
15. K. Alagarasu, P. Selvaraj, S. Swaminathan, S. Raghavan, G. Narendran, and P.R. Narayanan Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India Tuberculosis (Edin) 87 2007 535 543 (Pubitemid 47589041)
16. G. Catano, B.K. Agan, H. Kulkarni, V. Telles, V.C. Marconi, and M.J. Dolan Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations J Infect Dis 198 2008 72 80 (Pubitemid 351920292)
17. B. Ferwerda, G.S. Kibiki, M.G. Netea, W.M. Dolmans, and A.J. van der Ven The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania AIDS 21 2007 1375 1377 (Pubitemid 46883498)
18. K. Alagarasu, P. Selvaraj, S. Swaminathan, G. Narendran, and P.R. Narayanan 5′ Regulatory and 3′ Untranslated Region Polymorphisms of Vitamin D Receptor Gene in South Indian HIV and HIV-TB Patients J Clin Immunol 29 2009 196 204
19. P. Selvaraj, K. Alagarasu, S. Swaminathan, M. Harishankar, and G. Narendran CD209 gene polymorphisms in South Indian HIV and HIV-TB patients Infect Genet Evol 9 2009 256 262
20. K. Alagarasu, P. Selvaraj, S. Swaminathan, S. Raghavan, G. Narendran, and P.R. Narayanan CCR2, MCP-1, SDF-1α & DC-sign gene polymorphisms in HIV-1 infected patients with & without tuberculosis Indian J Med Res 130 2009 444 450
21. H. Hendel, S. Caillat-Zucman, H. Lebuanec, M. Carrington, S. O'Brien, and J.M. Andrieu New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS J Immunol 162 1999 6942 6946 (Pubitemid 29309424)
22. X. Gao, A. Bashirova, A.K. Iversen, J. Phair, J.J. Goedert, and S. Buchbinder AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis Nat Med 11 2005 1290 1292 (Pubitemid 41752907)
23. J.J. Just Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA [corrected] Hum Immunol 44 1995 156 169 (Pubitemid 26006724)
24. J. Choppin, F. Martinon, E. Gomard, E. Bahraoui, F. Connan, and M. Bouillot Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides J Exp Med 172 1990 889 899 (Pubitemid 20301235)
25. R. Busch, C.M. Hill, J.D. Hayball, J.R. Lamb, and J.B. Rothbard Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding J Immunol 147 1991 1292 1298
26. A. Kosc, J. Dubis, I. Wojciechowska, Z. Mackiewicz, W. Gorczyca, and A. Myc Studies on binding of HIV-1 p24gag peptide to HLA-Cw3+ cells Immunol Lett 64 1998 57 62 (Pubitemid 28553014)
27. K. Maenaka, T. Maenaka, H. Tomiyama, M. Takiguchi, D.I. Stuart, and E.Y. Jones Nonstandard peptide binding revealed by crystal structures of HLA-B (*)5101 complexed with HIV immunodominant epitopes J Immunol 165 2000 3260 3267
28. M.A. Luscher, K.S. MacDonald, J.J. Bwayo, F.A. Plummer, and B.H. Barber Sequence and peptide-binding motif for a variant of HLA-A (*)0214 (A (*)02142) in an HIV-1-resistant individual from the Nairobi Sex Worker cohort Immunogenetics 53 2001 10 14 (Pubitemid 32209407)
29. M. Cadogan, B. Austen, J.L. Heeney, and A.G. Dalgleish HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120 AIDS Res Hum Retroviruses 24 2008 845 855 (Pubitemid 351871667)
30. C. Kaplan, J.Y. Muller, C. Doinel, J.J. Lefrere, F. Paquez, and P. Rouger HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-1-seropositive subjects Hum Hered 40 1990 290 298 (Pubitemid 20343083)
31. B. Sriwanthana, T. Hodge, T.D. Mastro, C.S. Dezzutti, K. Bond, and H.A. Stephens HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand AIDS Res Hum Retroviruses 17 2001 719 734 (Pubitemid 32692410)
32. F.A. Koning, C.A. Jansen, J. Dekker, R.A. Kaslow, N. Dukers, and D. van Baarle Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour AIDS 18 2004 1117 1126 (Pubitemid 38738511)
33. L. Li, and M. Bouvier Structures of HLA-A (*)1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue J Immunol 172 2004 6175 6184 (Pubitemid 38621223)
34. A.M. Benham, M. Gromme, and J. Neefjes Allelic differences in the relationship between proteasome activity and MHC class I peptide loading J Immunol 161 1998 83 89 (Pubitemid 28285509)
35. M. Seeger, K. Ferrell, R. Frank, and W. Dubiel HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation J Biol Chem 272 1997 8145 8148 (Pubitemid 27147763)
36. G.W. Nelson, R. Kaslow, and D.L. Mann Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection Proc Natl Acad Sci USA 94 1997 9802 9807 (Pubitemid 27408145)
37. G.H. Bothamley Differences between HLA-B44 and HLA-B60 in patients with smear-positive pulmonary tuberculosis and exposed controls J Infect Dis 179 1999 1051 1052 (Pubitemid 29159361)
38. M. Qing, T. Li, Y. Han, Z. Qiu, and Y. Jiao Accelerating effect of human leukocyte antigen-Bw6 homozygosity on disease progression in Chinese HIV-1-infected patients J Acquir Immune Defic Syndr 41 2006 137 139
39. M. Carrington, and S.J. O'Brien The influence of HLA genotype on AIDS Annu Rev Med 54 2003 535 551 (Pubitemid 37386411)
40. V. Thammavongsa, M. Schaefer, T. Filzen, K.L. Collins, M. Carrington, and N. Bangia Assembly and intracellular trafficking of HLA-B (*)3501 and HLA-B (*)3503 Immunogenetics 61 2009 703 716
41. J. Huang, J.J. Goedert, E.J. Sundberg, T.D. Cung, P.S. Burke, and M.P. Martin HLA-B (*)35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses J Exp Med 206 2009 2959 2966
42. C.B. Willberg, K.E. Garrison, R.B. Jones, D.J. Meiklejohn, G. Spotts, and T.J. Liegler Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8 + T cells recognize vestigial CTL epitopes PLoS One 5 2010 e10249
43. A. Schneidewind, M.A. Brockman, R. Yang, R.I. Adam, B. Li, and S. Le Gall Escape from the dominant HLA-B27- restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication J Virol 81 2007 12,382 12,393
44. M. Altfeld, M.M. Addo, E.S. Rosenberg, F.M. Hecht, P.K. Lee, and M. Vogel Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection AIDS 17 2003 2581 2589
45. Y. Zhang, Y. Peng, H. Yan, K. Xu, M. Saito, and H. Wu Multilayered defense in HLA-B51-Associated HIV Viral Control J Immunol 187 2011 684 691
46. D. van Manen, N.A. Kootstra, B. Boeser-Nunnink, M.A. Handulle, A.B. van't Wout, and H. Schuitemaker Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection AIDS 23 2009 19 28
47. A.T. Makadzange, G. Gillespie, T. Dong, P. Kiama, J. Bwayo, and J. Kimani Characterization of an HLA-C-restricted CTL response in chronic HIV infection Eur J Immunol 40 2010 1036 1041
48. U. Shankarkumar, M. Thakar, S. Mehendale, R.S. Praranjape, and D. Mohanty Association of HLA B (*)3520, B (*)1801, and Cw (*)1507 with HIV-1 infection Maharashtra, India J Acquir Immune Defic Syndr 34 2003 113 114 (Pubitemid 37100121)
49. M.P. Martin, X. Gao, J.H. Lee, G.W. Nelson, R. Detels, and J.J. Goedert Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nat Genet 31 2002 429 434 (Pubitemid 35154456)
50. Y. Qi, M.P. Martin, X. Gao, L. Jacobson, J.J. Goedert, and S. Buchbinder KIR/HLA pleiotropism: protection against both HIV and opportunistic infections PLoS Pathog 2 2006 e79
51. A. Lopez-Vazquez, A. Mina-Blanco, J. Martinez-Borra, P.D. Njobvu, B. Suarez-Alvarez, and M.A. Blanco-Gelaz Interaction between KIR3DL1 and HLA-B (*)57 supertype alleles influences the progression of HIV-1 infection in a Zambian population Hum Immunol 66 2005 285 289 (Pubitemid 40395248)
52. P. Hansasuta, T. Dong, H. Thananchai, M. Weekes, C. Willberg, and H. Aldemir Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific Eur J Immunol 34 2004 1673 1679 (Pubitemid 39256049)
53. G. Alter, M.P. Martin, N. Teigen, W.H. Carr, T.J. Suscovich, and A. Schneidewind Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes J Exp Med 204 2007 3027 3036 (Pubitemid 350179568)
54. S. Boulet, R. Song, P. Kamya, J. Bruneau, N.H. Shoukry, and C.M. Tsoukas HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells J Immunol 184 2010 2057 2064
55. M.S. Parsons, S. Boulet, R. Song, J. Bruneau, N.H. Shoukry, and J.P. Routy Mind the gap: lack of association between KIR3DL1 (*)004/HLA-Bw4- induced natural killer cell function and protection from HIV infection J Infect Dis 202 Suppl. 3 2010 S356 S360
56. R. Rajalingam, Z. Du, A. Meenagh, L. Luo, V.J. Kavitha, and R. Pavithra-Arulvani Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations Immunogenetics 60 2008 207 217
57. A. Méndez, H. Granda, A. Meenagh, S. Contreras, R. Zavaleta, and M.F. Mendoza Study of KIR genes in tuberculosis patients Tissue Antigens 68 2006 386 389 (Pubitemid 44707049)
58. W. Jennes, S. Verheyden, C. Demanet, C.A. Adjé-Touré, B. Vuylsteke, and J.N. Nkengasong Resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands J Immunol 177 2006 6588 6592 (Pubitemid 44715020)
59. F. Pereyra, X. Jia, P.J. McLaren, A. Telenti, P.I. de Bakker, and B.D. Walker The major genetic determinants of HIV-1 control affect HLA class I peptide presentation Science 330 2010 1551 1557
60. X. Gao, G.W. Nelson, P. Karacki, M.P. Martin, J. Phair, and R. Kaslow Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS N Engl J Med 344 2001 1668 1675 (Pubitemid 32479964)
61. P. Selvaraj, H. Uma, A.M. Reetha, S.M. Kurian, T. Xavier, and R. Prabhakar HLA antigen profile in pulmonary tuberculosis patients & their spouses Indian J Med Res 107 1998 155 158 (Pubitemid 28221400)
62. A. Dubaniewicz, G. Moszkowska, and Z. Szczerkowska Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: preliminary report Tuberculosis (Edinb) 85 2005 259 267 (Pubitemid 40812364)
63. M. Jeannet, R. Sztajzel, N. Carpentier, B. Hirschel, and J.M. Tiercy HLA antigens are risk factors for development of AIDS J Acquir Immune Defic Syndr 2 1989 28 32 (Pubitemid 19127072)
64. P.A. Lacap, J.D. Huntington, M. Luo, N.J. Nagelkerke, T. Bielawny, and J. Kimani Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani sex worker cohort AIDS 22 2008 1029 1038 (Pubitemid 351769741)
65. S.I. Kapustin, T.I. Popova, A.A. Lyschov, A.V. Togo, K.M. Abdulkadyrov, and M.N. Blinov HLA-DR2 Frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype Pathol Oncol Res 3 1997 106 108
66. E. Prat, U. Tomaru, L. Sabater, D.M. Park, R. Granger, and N. Kruse HLA-DRB5 (*)0101 and -DRB1 (*)1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype J Neuroimmunol 167 2005 108 119 (Pubitemid 41242293)
67. S.B. LeBlanc, E.G. Naik, L. Jacobson, and R.A. Kaslow Association of DRB1 (*)1501 with disseminated Mycobacterium avium complex infection in North American AIDS patients Tissue Antigens 55 2000 17 23 (Pubitemid 30072692)
68. E. Naik, S. LeBlanc, J. Tang, L.P. Jacobson, and R.A. Kaslow The complexity of HLA class II (DRB1, DQB1, DM) associations with disseminated Mycobacterium avium complex infection among HIV-1-seropositive whites J Acquir Immune Defic Syndr 33 2003 140 145 (Pubitemid 36793146)
69. S.K. Sharma, K.K. Turaga, A. Balamurugan, P.K. Saha, R.M. Pandey, and N.K. Jain Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study Infect Genet Evol 3 2003 183 188 (Pubitemid 37168746)
70. A.E. Goldfeld, J.C. Delgado, S. Thim, M.V. Bozon, A.M. Uglialoro, and D. Turbay Association of an HLA-DQ allele with clinical tuberculosis JAMA 279 1998 226 228 (Pubitemid 28133786)
71. C. Liu, M. Carrington, R.A. Kaslow, X. Gao, C.R. Rinaldo, and L.P. Jacobson Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men J Acquir Immune Defic Syndr 37 2004 1313 1317 (Pubitemid 39281514)
72. F. Berretta, R.H. Butler, G. Diaz, N. Sanarico, J. Arroyo, and M. Fraziano Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity Tissue Antigens 62 2003 459 471 (Pubitemid 37475994)
73. D. Charron, R. Fauchet, and E. Albert Genetic diversity of HLA, functional and medical implication D. Charron, XIIth International histocompatibility workshop and conference 1997 EDK Paris
74. I.A. Doytchinova, and D.R. Flower In silico identification of supertypes for class II MHCs J Immunol 174 2005 7085 7095 (Pubitemid 40705674)
75. O. Neth, D.L. Jack, A.W. Dodds, H. Holzel, N.J. Klein, and M.W. Turner Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition Infect Immun 68 2000 688 693 (Pubitemid 30056524)
76. M. Saifuddin, M.L. Hart, H. Gewurz, Y. Zhang, and G.T. Spear Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1 J Gen Virol 81 2000 949 955 (Pubitemid 30189633)
77. D.L. Jack, R.C. Read, A.J. Tenner, M. Frosch, M.W. Turner, and N.J. Klein Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B J Infect Dis 184 2001 1152 1162 (Pubitemid 33010468)
78. C.A. Ogden, A. deCathelineau, P.R. Hoffmann, D. Bratton, B. Ghebrehiwet, and V.A. Fadok C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells J Exp Med 194 2001 781 795 (Pubitemid 32983014)
79. S. Thiel, T. Vorup-Jensen, C.M. Stover, W. Schwaeble, S.B. Laursen, and K. Poulsen A second serine protease associated with mannan-binding lectin that activates complement Nature 386 1997 506 510 (Pubitemid 27164078)
80. M.R. Dahl, S. Thiel, M. Matsushita, T. Fujita, A.C. Willis, and T. Christensen MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway Immunity 15 2001 127 135 (Pubitemid 32728326)
81. H.O. Madsen, M.L. Satz, B. Hogh, A. Svejgaard, and P. Garred Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America J Immunol 161 1998 3169 3175 (Pubitemid 28425746)
82. P. Garred, H.O. Madsen, U. Balslev, B. Hofmann, C. Pedersen, and J. Gerstoft Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin Lancet 349 1997 236 240 (Pubitemid 27050989)
83. T. Yajun, L. Lifeng, L. Peng, W. Anxu, J. Tianjun, and S. Xinliang Association between Mannose binding lectin and HIV infection and disease progression Mol Immunol 47 2009 632 638
84. J. Maas, A.M. de Roda Husman, M. Brouwer, A. Krol, R. Coutinho, and I. Keet Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study AIDS 12 1998 2275 2280 (Pubitemid 28526406)
85. M. Boniotto, S. Crovella, D. Pirulli, G. Scarlatti, A. Spano, and L. Vatta Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression Genes Immun 1 2000 346 348
86. A. Mangano, C. Rocco, S.M. Marino, D. Mecikovsky, F. Genre, and P. Aulicino Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression J Infect Dis 198 2008 694 700
87. D.A. Bleijs, T.B. Geijtenbeek, C.G. Figdor, and Y. van Kooyk DC-SIGN and LFA-1: a battle for ligand Trends Immunol 22 2001 457 463 (Pubitemid 32709981)
88. M. Pope, M.G. Betjes, N. Romani, H. Hirmand, P.U. Cameron, and L. Hoffman Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1 Cell 78 1994 389 398 (Pubitemid 24250804)
89. T.B. Geijtenbeek, D.S. Kwon, R. Torensma, S.J. van Vliet, G.C. van Duijnhoven, and J. Middel DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells Cell 100 2000 587 597
90. T.B. Geijtenbeek, S.J. Van Vliet, E.A. Koppel, M. Sanchez-Hernandez, C.M. Vandenbroucke-Grauls, and B. Appelmelk Mycobacteria target DC-SIGN to suppress dendritic cell function J Exp Med 197 1 2003 7 17 (Pubitemid 36110253)
91. M.P. Martin, M.M. Lederman, H.B. Hutcheson, J.J. Goedert, G.W. Nelson, and Y. van Kooyk Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection J Virol 78 2004 14053 14056 (Pubitemid 39612803)
92. L.B. Barreiro, O. Neyrolles, C.L. Babb, L. Tailleux, H. Quach, and K. McElreavey Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis PLoS Med 3 2006 e20
93. F.O. Vannberg, S.J. Chapman, C.C. Khor, K. Tosh, S. Floyd, and D. Jackson-Sillah CD209 genetic polymorphism and tuberculosis disease PLoS One 3 2008 e1388
94. A. Sakuntabhai, C. Turbpaiboon, I. Casademont, A. Chuansumrit, T. Lowhnoo, and A. Kajaste-Rudnitski A variant in the CD209 promoter is associated with severity of dengue disease Nat Genet 37 2005 507 513 (Pubitemid 40617279)
95. N. Tokuda, and R.B. Levy 1,25-dihydroxyvitamin D3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes Proc Soc Exp Biol Med 211 1996 244 250
96. G. Chandra, P. Selvaraj, M.S. Jawahar, V.V. Banurekha, and P.R. Narayanan Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis J Clin Immunol 24 2004 249 257 (Pubitemid 39030672)
97. S.A. Kliewer, K. Umesono, D.J. Mangelsdorf, and R.M. Evans Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling Nature 355 1992 446 449
98. S. Kim, N.K. Shevde, and J.W. Pike 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts J Bone Miner Res 20 2005 305 317
99. W.F. Rigby, M. Waugh, and R.F. Graziano Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3 Blood 76 1990 189 197 (Pubitemid 20220810)
100. R.I. Connor, and W.F. Rigby 1 alpha, 25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1 Biochem Biophys Res Commun 176 1991 852 859
101. C.D. Pauza, R. Kornbluth, P. Emau, D.D. Richman, and L.J. Deftos Vitamin D3 compounds regulate human immunodeficiency virus type 1 replication in U937 monoblastoid cells and in monocyte-derived macrophages J Leukoc Biol 53 1993 157 164 (Pubitemid 23100158)
102. J. Nevado, S.P. Tenbaum, A.I. Castillo, A. Sanchez-Pacheco, and A. Aranda Activation of the human immunodeficiency virus type I long terminal repeat by 1alpha, 25-dihydroxyvitamin D3 J Mol Endocrinol 38 2007 587 601 (Pubitemid 47019061)
103. A.G. Uitterlinden, Y. Fang, J.B. Van Meurs, H.A. Pols, and J.P. Van Leeuwen Genetics and biology of vitamin D receptor polymorphisms Gene 338 2004 143 156 (Pubitemid 39094759)
104. H. Arai, K.I. Miyamoto, M. Yoshida, H. Yamamoto, Y. Taketani, and K. Morita The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene J Bone Miner Res 16 2001 1256 1264 (Pubitemid 32574654)
105. J.A. Halsall, J.E. Osborne, L. Potter, J.H. Pringle, and P.E. Hutchinson A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma Br J Cancer 91 2004 765 770 (Pubitemid 39141638)
106. Y. Barber, C. Rubio, E. Fernandez, M. Rubio, and J. Fibla Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users J Infect Dis 184 2001 1279 1288 (Pubitemid 33055572)
107. G. Nieto, Y. Barber, M.C. Rubio, M. Rubio, and J. Fibla Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients J Steroid Biochem Mol Biol 89-90 2004 199 207 (Pubitemid 38844283)
108. E. Villamor A potential role for vitamin D on HIV infection? Nutr Rev 64 2006 226 233 (Pubitemid 43953286)
109. M.S. de la Torre, C. Torres, G. Nieto, S. Vergara, A.J. Carrero, and J. Macias Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users J Infect Dis 197 2008 405 410 (Pubitemid 351263422)
110. E.A. Misch, and T.R. Hawn Toll like receptor polymorphisms and susceptibility to human disease Clin Sci 114 2008 347 360 (Pubitemid 351397384)
111. P.Y. Bochud, M. Hersberger, P. Taffé, M. Bochud, C.M. Stein, and S.D. Rodrigues Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection AIDS 21 2007 441 446
112. S. Gruenheid, E. Pinner, M. Desjardins, and P. Gros Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome J Exp Med 185 1997 717 730 (Pubitemid 27098156)
113. M.D. Fleming, C.C. 3rd Trenor, M.A. Su, D. Foernzler, D.R. Beier, and W.F. Dietrich Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene Nat Genet 16 1997 383 386 (Pubitemid 27323306)
114. C.H. Barton, T.E. Biggs, S.T. Baker, H. Bowen, and P.G. Atkinson Nramp1: a link between intracellular iron transport and innate resistance to intracellular pathogens J Leukoc Biol 66 1999 757 762 (Pubitemid 29532036)
115. H.T. Li, T.T. Zhang, Y.Q. Zhou, Q.H. Huang, and J. Huang SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a metaanalysis Int J Tuberc Lung Dis 10 2006 3 12 (Pubitemid 43266270)
116. J.M. McDermid, M.F. Schim van der Loeff, A. Jaye, B.J. Hennig, C. Bates, and J. Todd Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction Am J Clin Nutr 90 2009 225 233
117. H.D. Shin, C. Winkler, J.C. Stephens, J. Bream, H. Young, and J.J. Goedert Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10 Proc Natl Acad Sci USA 97 2000 14467 14472 (Pubitemid 32016599)
118. A. Vasilescu, S.C. Heath, R. Ivanova, H. Hendel, H. Do, and A. Mazoyer Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression Genes Immun 4 2003 441 449 (Pubitemid 38967609)
119. P. An, D. Vlahov, J.B. Margolick, J. Phair, T.R. O'Brien, and J. Lautenberger A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4 + T cell depletion in human immunodeficiency virus-1-infected individuals J Infect Dis 188 2003 228 231 (Pubitemid 36898154)
120. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8 + T cells Science 270 1995 1811 1815
121. C.C. Bleul, M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, and J. Sodroski The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 382 1996 829 833 (Pubitemid 26299570)
122. B. Moser, and P. Loetscher Lymphocyte traffic control by chemokines Nat Immunol 2 2001 123 128 (Pubitemid 33707929)
123. W. Peters, H.M. Scott, H.F. Chambers, J.L. Flynn, I.F. Charo, and J.D. Ernst Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis Proc Natl Acad Sci USA 98 2001 7958 7963 (Pubitemid 32642669)
124. S. Shalekoff, and C.T. Tiemessen Circulating levels of stromal cell-derived factor 1alpha and interleukin 7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes AIDS Res Hum Retroviruses 19 2003 461 468 (Pubitemid 36793766)
125. E. Gonzalez, H. Kulkarni, H. Bolivar, A. Mangano, R. Sanchez, and G. Catano The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility Science 307 2005 1434 1440 (Pubitemid 40321934)
126. M. Mamtani, S. Mummidi, V. Ramsuran, M. Pham, R. Maldonado, and K. Begum Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population J Infect Dis 203 2011 1590 1594
127. R. Colobran, P. Adreani, Y. Ashhab, A. Llano, J.A. Este, and O. Dominguez Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients J Immunol 174 2005 5655 5664 (Pubitemid 40593207)
128. H. Liu, D. Chao, E.E. Nakayama, H. Taguchi, M. Goto, and X. Xin Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression Proc Natl Acad Sci USA 96 1999 4581 4585 (Pubitemid 29190379)
129. N. Wichukchinda, E.E. Nakayama, A. Rojanawiwat, P. Pathipvanich, W. Auwanit, and S. Vongsheree Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females AIDS 20 2006 189 196
130. E. Gonzalez, R. Dhanda, M. Bamshad, S. Mummidi, R. Geevarghese, and G. Catano Global survey of genetic variation in CCR5, RANTES, and MIP-1 alpha: impact on the epidemiology of the HIV-1 pandemic Proc Natl Acad Sci USA 98 2001 5199 5204 (Pubitemid 32397106)
131. P. An, G.W. Nelson, L. Wang, S. Donfield, J.J. Goedert, and J. Phair Modulating influence on HIV/AIDS by interacting RANTES gene variants Proc Natl Acad Sci USA 99 2002 10002 10007 (Pubitemid 34831162)
132. Y. Koizumi, S. Kageyama, Y. Fujiyama, M. Miyashita, R. Lwembe, and K. Ogino RANTES-28G delays and DC-SIGN-139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs AIDS Res Hum Retroviruses 23 2007 713 719 (Pubitemid 46867470)
133. X.Y. Zhao, S.S. Lee, K.H. Wong, K.C. Chan, S. Ma, and W.C. Yam Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese Eur J Immunogenet 31 2004 179 183 (Pubitemid 39049863)
134. G.S. Cooke, K. Tosh, P.A. Ramaley, P. Kaleebu, J. Zhuang, and J.S. Nakiyingi A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease J Infect Dis 194 2006 666 669 (Pubitemid 44297853)
135. P. Suresh, A. Wanchu, R.K. Sachdeva, and A. Bhatnagar Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India J Clin Immunol 26 2006 476 484 (Pubitemid 44440181)
136. F. Vidal, C. Vilades, P. Domingo, M. Broch, E. Pedrol, and D. Dalmau Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele J Acquir Immune Defic Syndr 40 2005 527 531 (Pubitemid 41669155)
137. A. Rathore, A. Chatterjee, P. Sivarama, N. Yamamoto, P.K. Singhal, and T.N. Dhole Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians J Med Virol 80 2008 1133 1141 (Pubitemid 351705991)
138. P. Selvaraj, K. Alagarasu, B. Singh, and K. Afsal CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India Int J Immunogenetics 2011 10.1111/j.1744-313X.2011.01021.x [Epub ahead of print June 27]
139. E. Gonzalez, B.H. Rovin, L. Sen, G. Cooke, R. Dhanda, and S. Mummidi HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels Proc Natl Acad Sci USA 99 2002 13795 13800 (Pubitemid 35215460)
140. C. Winkler, W. Modi, M.W. Smith, G.W. Nelson, X. Wu, and M. Carrington Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science 279 1998 389 393
141. S. Mummidi, S.S. Ahuja, E. Gonzalez, S.A. Anderson, E.N. Santiago, and K.T. Stephan Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression Nat Med 4 1998 786 793 (Pubitemid 28331019)
142. J.P. Ioannidis, P.S. Rosenberg, J.J. Goedert, L.J. Ashton, T.L. Benfield, and S.P. Buchbinder Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data Ann Intern Med 135 2001 782 795 (Pubitemid 33051262)
143. O. Chaudhary, K. Rajsekar, I. Ahmed, R. Verma, M. Bala, and R. Bhasin Polymorphic variants in DC-SIGN, DC-SIGNR and SDF-1 in high risk seronegative and HIV-1 patients in Northern Asian Indians J Clin Virol 43 2008 196 201
144. Y. Wang, X. Wang, J. Peng, L. Chen, J. Cheng, and S. Nie Short communication: sdf-1-3′A gene mutation is correlated with increased susceptibility to HIV type 1 infection by sexual transmission in Han Chinese AIDS Res Hum Retroviruses 24 2008 1341 1345
145. E.A. Berger, P.M. Murphy, and J.M. Farber Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu Rev Immunol 17 1999 657 700 (Pubitemid 29241137)
146. J.P. Moore Coreceptors: implications for HIV pathogenesis and therapy Science 276 5309 1997 51 52 (Pubitemid 27161239)
147. W.A. Paxton, R. Liu, S. Kang, L. Wu, T.R. Gingeras, and N.R. Landau Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines Virology 244 1 1998 66 73 (Pubitemid 28384126)
148. E. Gonzalez, M. Bamshad, N. Sato, S. Mummidi, R. Dhanda, and G. Catano Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes Proc Natl Acad Sci USA 96 1999 12004 12009 (Pubitemid 29502848)
149. G. Kaur, P. Singh, C.C. Rapthap, N. Kumar, M. Vajpayee, and S.K. Sharma Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians Hum Immunol 68 2007 454 461 (Pubitemid 46616972)
150. L. Nyugen, M. Li, T. Chaowanachan, D.J. Hu, S. Vanichseni, and P.A. Mock CCR5 promoter haplogroups associated with HIV-1 discordant progression in Thai injection drug users AIDS 18 2004 1327 1333 (Pubitemid 38822712)
151. B.M. Saunders, S.L. Fernando, R. Sluyter, W.J. Britton, and J.S. Wiley A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria J Immunol 171 2003 5442 5446 (Pubitemid 37432832)
152. C.M. Li, S.J. Campbell, D.S. Kumararatne, R. Bellamy, C. Ruwende, and K.P. McAdam Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population J Infect Dis 186 2002 1458 1462 (Pubitemid 35286113)
153. V. Sambasivan, K.J. Rama Murthy, R. Reddy, V. Vijayalakshimi, and Q. Hasan P2X7 gene polymorphisms and risk assessment for pulmonary tuberculosis in Asian Indians Disease Markers 28 2010 43 48
154. R.J. Hill, S. Zozulya, Y.L. Lu, K. Ward, M. Gishizky, and B. Jallal The lymphoid protein tyrosine phosphatase Lyp interacts with the adapter molecule Grb2 and function as a negative regulator of T cell activation Exp Haematol 30 2002 237 244 (Pubitemid 34203730)
155. L.M. Gomez, J.M. Anaya, and J. Martin Genetic influence of PTPN22 R620 W polymorphism in tuberculosis Hum Immunol 66 2005 1242 1247 (Pubitemid 44294628)
156. H. Lamsyah, B. Rueda, L. Baassi, R. Elaouad, N. Bottini, and K. Sadki Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population Tissue Antigens 74 2009 228 232
157. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 24 2003 99 103 (Pubitemid 36834849)
158. P. An, G. Bleiber, P. Duggal, G. Nelson, M. May, and B. Mangeat APOBEC3G genetic variants and their influence on the progression to AIDS J Virol 78 2004 11070 11076 (Pubitemid 39299647)
159. H. Do, A. Vasilescu, G. Diop, T. Hirtzig, S.C. Heath, and C. Coulonges Exhaustive genotyping of the CEM15(APOBEC3G) gene and absence of association with AIDS progression in a French cohort J Infect Dis 191 2005 159 163 (Pubitemid 40096372)
160. P. An, L.H. Wang, H. Hutcheson-Dilks, G. Nelson, S. Donfield, and J.J. Goedert Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS PLoS Pathog 3 2007 e88
161. G. Bleiber, M. May, R. Martinez, P. Meylan, and J. Ott Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression J Virol 79 2005 12,674 12,680
162. E.C. Speelmon, D. Livingston-Rosanoff, S.S. Li, Q. Vu, J. Bui, and D.E. Geraghty Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection J Virol 80 2006 2463 2471 (Pubitemid 43271552)
163. D. van Manen, M.A.N. Rits, C. Beugeling, K. van Dort, and H. Schuitemaker The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection PLoS Pathog 4 2008 e18
164. J. Fellay, K.V. Shianna, D. Ge, S. Colombo, B. Ledergerber, and M. Weale A whole-genome association study of major determinants for host control of HIV-1 Science 317 2007 944 947 (Pubitemid 47301321)
165. J. Fellay, D. Ge, K.V. Shianna, S. Colombo, B. Ledergerber, and E.T. Cirulli Common genetic variation and the control of HIV-1 in humans PLoS Genet 5 2009 e1000791
166. K. Pelak, D.B. Goldstein, N.M. Walley, J. Fellay, D. Ge, and K.V. Shianna Host determinants of HIV-1 control in African Americans J Infect Dis 201 2010 1141 1149
167. S.V. Ramagopalan, N.J. Maugeri, L. Handunnetthi, M.R. Lincoln, S.-M. Orton, and D.A. Dyment Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1 (*)1501 is regulated by vitamin D PLoS Genet 5 2009 e1000369
168. F.O. Sanchez, M.V. Prasad Linga Reddy, K. Sakuraba, M. Stahle, and M.E. Alarcon-Riquelme IFN-regulatory factor 5 gene variants interact with the class I MHC locus in the Swedish Psoriasis population J Investig Dermatol 128 2008 1704 1709 (Pubitemid 351847380)
169. G.B. Cohen, R.T. Gandhi, D.M. Davis, O. Mandelboim, B.K. Chen, and J.L. Strominger The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells Immunity 10 1999 661 671 (Pubitemid 29302919)
170. M. Caws, G. Thwaites, S. Dunstan, T.R. Hawn, N.T. Lan, and N.T. Thuong The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis PLoS Pathog 4 2008 e1000034
171. Indian Genome Variation Consortium Genetic landscape of the people of India: a canvas for disease gene exploration J Genet 87 2008 3 20
172. G. Catano, H. Kulkarni, W. He, V.C. Marconi, B.K. Agan, and M. Landrum HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B (*)57 alleles PLoS One 3 2008 e3636
173. M. Ciccozzi, I. Bon, and M. Ciotti Do the HIV-1 subtypes circulating in Italy resemble the Red Queen running in Carroll's novel? New Microbiol 33 2010 179 181
174. R. Jayaraman Phase variation and adaptation in bacteria: a 'Red Queen's Race' Curr Sci 100 2011 1163 1171